A wave of cutbacks is erasing nearly 807 jobs at Massachusetts life sciences companies and reshaping a sector that is key to the state's economy, with global drug makers stepping up to play a larger role as home grown players shrink operations.
Local make cuts as global firms feel pinch of tight credit market.